Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Background Eosinophilic granulomatosis with polyangiitis (EGPA), a rare vasculitis with
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
LA Manka, VP Guntur, JL Denson, RM Dunn… - Annals of Allergy …, 2021 - Elsevier
Background Eosinophilic granulomatosis with polyangiitis (EGPA), a rare vasculitis with
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
[引用][C] Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
LA Manka, VP Guntur, JL Denson, RM Dunn… - Annals of Allergy …, 2021 - cir.nii.ac.jp
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with
polyangiitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
polyangiitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
LA Manka, VP Guntur, JL Denson, RM Dunn… - Annals of Allergy …, 2021 - annallergy.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA), a rare vasculitis with
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
LA Manka, VP Guntur, JL Denson… - Annals of Allergy …, 2021 - europepmc.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA), a rare vasculitis with
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
LA Manka, VP Guntur, JL Denson… - Annals of allergy …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Eosinophilic granulomatosis with polyangiitis (EGPA), a rare vasculitis with
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …
substantial morbidity, is characterized by asthma, eosinophilia, sinusitis, pulmonary …